Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A new dendritic cell vaccine generated with interleukin-3 and interferon-beta induces CD8+ T cell responses against NA17-A2 tumor peptide in melanoma patients.
Trakatelli M, Toungouz M, Blocklet D, Dodoo Y, Gordower L, Laporte M, Vereecken P, Sales F, Mortier L, Mazouz N, Lambermont M, Goldman S, Coulie P, Goldman M, Velu T. Trakatelli M, et al. Among authors: velu t. Cancer Immunol Immunother. 2006 Apr;55(4):469-74. doi: 10.1007/s00262-005-0056-z. Epub 2005 Aug 20. Cancer Immunol Immunother. 2006. PMID: 16133111 Free PMC article. Clinical Trial.
Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate.
Salcedo M, Bercovici N, Taylor R, Vereecken P, Massicard S, Duriau D, Vernel-Pauillac F, Boyer A, Baron-Bodo V, Mallard E, Bartholeyns J, Goxe B, Latour N, Leroy S, Prigent D, Martiat P, Sales F, Laporte M, Bruyns C, Romet-Lemonne JL, Abastado JP, Lehmann F, Velu T. Salcedo M, et al. Among authors: velu t. Cancer Immunol Immunother. 2006 Jul;55(7):819-29. doi: 10.1007/s00262-005-0078-6. Epub 2005 Sep 27. Cancer Immunol Immunother. 2006. PMID: 16187085 Free PMC article. Clinical Trial.
Therapeutic efficacy of antitumor dendritic cell vaccinations correlates with persistent Th1 responses, high intratumor CD8+ T cell recruitment and low relative regulatory T cell infiltration.
Driessens G, Gordower L, Nuttin L, Stordeur P, Blocklet D, Egrise D, Velu T, Bruyns C. Driessens G, et al. Among authors: velu t. Cancer Immunol Immunother. 2008 Dec;57(12):1745-56. doi: 10.1007/s00262-008-0500-y. Epub 2008 Mar 28. Cancer Immunol Immunother. 2008. PMID: 18369621 Free PMC article.
[Anti-tumor immunotherapy based on dendritic cells].
Toungouz M, Lambermont M, Velu T, Buelens C, Vanderheyde N, Bartholomé E, Willems F, Gangji D, Goldman M. Toungouz M, et al. Among authors: velu t. J Soc Biol. 2001;195(1):19-23. J Soc Biol. 2001. PMID: 11530495 Review. French.
[New therapeutic approachs in melanoma].
Mortier L, Marchetti P, Gordower L, Charbonnier-Hatzfeld AS, Toungouz M, Velu T. Mortier L, et al. Among authors: velu t. Rev Med Brux. 2004 Jun;25(3):153-9. Rev Med Brux. 2004. PMID: 15291447 Review. French.
144 results